186 related articles for article (PubMed ID: 30765454)
21. Plurihormonal ACTH-GH Pituitary Adenoma: Case Report and Systematic Literature Review.
Roca E; Mattogno PP; Porcelli T; Poliani L; Belotti F; Schreiber A; Maffezzoni F; Fontanella MM; Doglietto F
World Neurosurg; 2018 Jun; 114():e158-e164. PubMed ID: 29501516
[TBL] [Abstract][Full Text] [Related]
22. [Use of cabergoline in persisting Cushing's disease].
Illouz F; Dubois-Ginouves S; Laboureau S; Rohmer V; Rodien P
Ann Endocrinol (Paris); 2006 Sep; 67(4):353-6. PubMed ID: 17072242
[TBL] [Abstract][Full Text] [Related]
23. Cyclic Cushing's disease with paradoxical response to dexamethasone.
Checchi S; Brilli L; Guarino E; Ciuoli C; Di Cairano G; Mazzucato P; Pacini F
J Endocrinol Invest; 2005 Sep; 28(8):741-5. PubMed ID: 16277172
[TBL] [Abstract][Full Text] [Related]
24. A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule.
Timmers HJ; van Ginneken EM; Wesseling P; Sweep CG; Hermus AR
J Endocrinol Invest; 2006 Nov; 29(10):934-9. PubMed ID: 17185905
[TBL] [Abstract][Full Text] [Related]
25. The coexistence of infundibular pituicytoma and Cushing's disease due to pituitary adenoma: A case report.
Gezer E; Selek A; Cetinarslan B; Canturk Z; Tarkun I; Ceylan S
Endocr Regul; 2019 Oct; 53(4):263-267. PubMed ID: 31734654
[TBL] [Abstract][Full Text] [Related]
26. Reduction of a pancreatic tumor after total removal of an ACTH secreting pituitary tumor: differential diagnosis of Cushing's syndrome.
Hashiba T; Saitoh Y; Asanuma N; Kouhara H; Maruo T; Fujinaka T; Kasayama S; Yoshimine T
Endocr J; 2006 Apr; 53(2):203-8. PubMed ID: 16618978
[TBL] [Abstract][Full Text] [Related]
27. Pituitary-targeted medical therapy of Cushing's disease.
Alexandraki KI; Grossman AB
Expert Opin Investig Drugs; 2008 May; 17(5):669-77. PubMed ID: 18447593
[TBL] [Abstract][Full Text] [Related]
28. Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.
Carr SB; Kleinschmidt-DeMasters BK; Kerr JM; Kiseljak-Vassiliades K; Wierman ME; Lillehei KO
J Neurosurg; 2018 Nov; 129(5):1260-1267. PubMed ID: 29219752
[TBL] [Abstract][Full Text] [Related]
29. Occult eutopic Cushing's syndrome--failure of simultaneous bilateral petrosal sinus sampling to diagnose pituitary-dependent Cushing's syndrome.
Heppner C; Becker K; Saeger W; Günther RW; Allolio B; Krone W; Winkelmann W
Eur J Endocrinol; 1997 Jul; 137(1):74-8. PubMed ID: 9242205
[TBL] [Abstract][Full Text] [Related]
30. Preclinical Cushing's disease characterized by massive adrenal hyperplasia and hormonal changes after three years of metyrapone therapy.
Ohmori N; Nomura K; Ohmori K; Takano K
Endocr J; 2007 Jun; 54(3):391-7. PubMed ID: 17446657
[TBL] [Abstract][Full Text] [Related]
31. Cushing's disease: a multidisciplinary overview of the clinical features, diagnosis, and treatment.
Buliman A; Tataranu LG; Paun DL; Mirica A; Dumitrache C
J Med Life; 2016; 9(1):12-18. PubMed ID: 27974908
[TBL] [Abstract][Full Text] [Related]
32. The management of Cushing's disease - from investigation to treatment.
Juszczak A; Grossman A
Endokrynol Pol; 2013; 64(2):166-74. PubMed ID: 23653280
[TBL] [Abstract][Full Text] [Related]
33. Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6).
Correa-Silva SR; Nascif SO; Molica P; Sá LB; Vieira JG; Lengyel AM
Clin Endocrinol (Oxf); 2010 Jan; 72(1):70-5. PubMed ID: 19453623
[TBL] [Abstract][Full Text] [Related]
34. Potential role for retinoic acid in patients with Cushing's disease.
Pecori Giraldi F; Ambrogio AG; Andrioli M; Sanguin F; Karamouzis I; Corsello SM; Scaroni C; Arvat E; Pontecorvi A; Cavagnini F
J Clin Endocrinol Metab; 2012 Oct; 97(10):3577-83. PubMed ID: 22851491
[TBL] [Abstract][Full Text] [Related]
35. The role of somatostatin analogs in Cushing's disease.
van der Hoek J; Lamberts SW; Hofland LJ
Pituitary; 2004; 7(4):257-64. PubMed ID: 16132202
[TBL] [Abstract][Full Text] [Related]
36. Pathophysiology and treatment of subclinical Cushing's disease and pituitary silent corticotroph adenomas [Review].
Kageyama K; Oki Y; Nigawara T; Suda T; Daimon M
Endocr J; 2014; 61(10):941-8. PubMed ID: 24974880
[TBL] [Abstract][Full Text] [Related]
37. Pituicytoma in a patient with Cushing's disease: case report and review of the literature.
Schmalisch K; Schittenhelm J; Ebner FH; Beuschlein F; Honegger J; Beschorner R
Pituitary; 2012 Dec; 15 Suppl 1():S10-6. PubMed ID: 20945102
[TBL] [Abstract][Full Text] [Related]
38. Different imaging characteristics of concurrent pituitary adenomas in a patient with Cushing's disease.
Mehta GU; Montgomery BK; Raghavan P; Sharma S; Nieman LK; Patronas N; Oldfield EH; Chittiboina P
J Clin Neurosci; 2015 May; 22(5):891-4. PubMed ID: 25827866
[TBL] [Abstract][Full Text] [Related]
39. Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas.
Woo YS; Isidori AM; Wat WZ; Kaltsas GA; Afshar F; Sabin I; Jenkins PJ; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2005 Aug; 90(8):4963-9. PubMed ID: 15886242
[TBL] [Abstract][Full Text] [Related]
40. Long-term remission of cyclic Cushing's disease that was diagnosed and treated surgically in non-active phase.
Asano S; Ooka H; Okazaki R; Ishikawa T; Ochiai H; Nakashima M; Ide F; Hasegawa I; Miyawaki S; Nakaguchi H; Murakami M; Ogino Y; Takano K; Matsuno A
Endocr J; 2007 Jun; 54(3):407-12. PubMed ID: 17446656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
